Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTND3P6 is a pseudogene, which means it is a genomic DNA sequence similar to a known gene (MT-ND3) but is nonfunctional due to accumulated mutations. Pseudogenes do not encode functional proteins and are generally not considered therapeutic targets. The MT-ND3 gene itself codes for a subunit of mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase), but MTND3P6 is considered a nonfunctional, noncoding sequence. There is no evidence that MTND3P6 is involved in biological processes, disease, or drug interactions[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 pseudogene 6 (MTND3P6).